Cargando…
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
PURPOSE: Pancreatic carcinoma is the neoplasia with the major mortality, and main standard treatments in this cancer increase survival but do not lead to complete recovery of the patient. The aim of this study was to evaluate the efficacy of Abraxane(®) (nab-paclitaxel) in Italian patients with meta...
Autores principales: | De Luca, Rossella, Blasi, Livio, Alù, Massimiliano, Gristina, Valerio, Cicero, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016012/ https://www.ncbi.nlm.nih.gov/pubmed/29950811 http://dx.doi.org/10.2147/DDDT.S165851 |
Ejemplares similares
-
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life
por: De Luca, Rossella, et al.
Publicado: (2019) -
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer
por: Rapposelli, Ilario Giovanni, et al.
Publicado: (2021) -
nab-Paclitaxel for the treatment of pancreatic cancer
por: Kim, George
Publicado: (2017) -
Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
por: Han, Sung Yong, et al.
Publicado: (2020) -
Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer
por: Winer, Arthur, et al.
Publicado: (2021)